reviewNature BiotechnologyJan 1, 2007Closed access

Dimethyl sulfoxide to vorinostat: development of this histone deacetylase inhibitor as an anticancer drug

PAPaul A. MarksRBRonald Breslow

Memorial Sloan Kettering Cancer Center · Columbia University

PubMed
Indexed incrossrefpubmed

Abstract

No abstract available for this paper.

Citation impact

1,198
total citations
FWCI
33.37
Percentile
100%
References
51
Citations per year

Authors

2

Topics & keywords

Topics
Keywords
  • Vorinostat
  • Histone deacetylase
  • Histone deacetylase inhibitor
  • Chemistry
  • Cancer research
  • Histone
  • Apoptosis
  • Acetylation
No related works found for this paper.

Funding